Articles From: iShares Leads Global ETF Industry Flows with $102.8bn in 2014 to ISSI Announces Preliminary December Quarter Revenue Results


2015/1/5
BlackRock, Inc. (NYSE: BLK) announced today that its iShares business led the global industry by capturing $102.8bn in new flows in 2014, 31% of the record-breaking $330.7bn global exchange traded fund (ETF) market flows.
Sign-up for iShares Leads Global ETF Industry Flows with $102.8bn in 2014 investment picks
2014/12/10
As of December 9, 2014, iShares MSCI ACWI Low Carbon Target ETF (CRBN) began participating in the NYSE Arca ETP Program on its listing market, NYSE Arca.
Sign-up for iShares MSCI ACWI Low Carbon Target ETF (CRBN) to Participate in NYSE Arca ETP Incentive Program investment picks
2015/2/26
As of February 26, 2015, iShares U.S. Fixed Income Balanced Risk ETF (INC) will begin participating in the BATS Competitive Liquidity (“CLP”) Program on the BATS listing market.
Sign-up for iShares U.S. Fixed Income Balanced Risk ETF Joins BATS Competitive Liquidity Program investment picks
2015/1/5
-- Collaboration Combines Isis' RNA-Targeted Technology With Expertise of Janssen in Autoimmune Disorders and Therapeutic Formulation --
Sign-up for Isis Pharmaceuticals Announces Collaboration With Janssen to Discover and Develop RNA-Targeted Therapeutics for Autoimmune Diseases in the GI Tract investment picks
2015/1/6
Isis-owned Subsidiary Launched to Conduct Development and Commercialization of Isis' Lipid Franchise Drugs CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Appoints Paula Soteropoulos As President And Chief Executive Officer Of Akcea Therapeutics investment picks
2015/1/5
Isis Strengthens Management Team Adding Strategic Business and Strategic Marketing Expertise CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Appoints Sarah Boyce As Chief Business Officer investment picks
2015/2/5
--Fourth Drug to Enter Development Under Broad Strategic Collaboration CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancing New Drug Into Development to Treat a Neurodegenerative Disease investment picks
2015/3/2
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Earns $15 Million From GSK for Advancing ISIS-TTR Rx investment picks
2015/2/10
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Earns $5 Million Milestone Payment From Biogen Idec investment picks
2015/1/14
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Earns $7M for Advancing ISIS-SMN Rx in Children With Spinal Muscular Atrophy investment picks
2014/12/16
ISIS-DMPK Rx Extends the Targeting of Antisense Drugs to Include Muscle Tissue CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Initiates Phase 1/2 Study of ISIS-DMPK Rx in Patients With Myotonic Dystrophy Type 1 investment picks
2015/2/3
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Reports Data From Phase 2 Study of ISIS-PTP1B Rx in Patients With Type 2 Diabetes investment picks
2014/12/7
Seven-fold lower incidence of VTE in patients treated with ISIS-FXI Rx compared with enoxaparin Data published in New England Journal of Medicine and featured at the American Society of Hematology annual meeting Isis to host a webcast at 9:00 a.m. ET on Monday, December 8, 2014 CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx for the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery investment picks
2015/1/8
Isis Pharmacueticals Inc. (ISIS) said Thursday it expects to "significantly" improve on its 2014 guidance, ending the year with a pro forma net operating loss in the mid to high teens and more than $725 million cash.
Sign-up for Isis Pharmaceuticals shares rise 2.8% after company raises outlook investment picks
2015/1/8
Strong Performance represents success of novel business strategy CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Significantly Improves Upon 2014 Financial Guidance investment picks
2015/1/2
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/2/4
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals to Present at Upcoming Investor Conferences investment picks
2014/12/5
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Lifetime Achievement Award investment picks
2015/2/27
- Isis Outperforms 2014 Projections for Pro Forma Net Operating Loss and Year-end Cash - Isis Achieves Profitable Fourth Quarter - More than $230 Million in Payments from Partners Drives Significantly Improved Financial Results - Conference Call Webcast Friday, February 27, 10:30 a.m. ET at www.isispharm.com CARLSBAD, Calif.
Sign-up for Isis Reports Financial Results and Highlights for 2014 investment picks
2015/2/25
ST. LOUIS , Feb.
Sign-up for Isle of Capri Casinos, Inc. Announces Fiscal 2015 Third Quarter Results investment picks
2015/2/18
ST. LOUIS , Feb.
Sign-up for Isle Of Capri Casinos, Inc. Will Report FY 2015 Third Quarter Results investment picks
2015/1/6
Kenon's shares will commence trading on the NYSE on or about January 6, 2015 on a when-issued basis under the symbol "KEN WI" SINGAPORE , Jan.
Sign-up for Israel Corporation Approves Spin-Off of Kenon investment picks
2015/1/6
TORONTO , Jan.
Sign-up for ISS Recommends Duluth Metals shareholders approve the arrangement with Antofagasta investment picks
2014/12/19
Terence Bernard Wise, the largest shareholder and member of the board of directors of Forward Industries, Inc. (NASDAQ: FORD), is pleased to announce that ISS, the world’s leading provider of corporate governance solutions, recommends Forward Industries shareholders vote on the GOLD proxy card for Mr.
Sign-up for ISS Recommends Forward Industries Shareholders Vote on the GOLD Proxy Card for Substantial Change investment picks
2015/1/21
ISS Also Recommends That GFI Shareholders Tender Their Shares Into BGC's "Economically Superior" Offer NEW YORK , Jan.
Sign-up for ISS Recommends GFI Shareholders Vote Against "Economically Inferior" Merger With CME investment picks
2014/12/22
http://media3.marketwire.com/logos/20140725-OSK_logo_200.jpg http://www.ccnmatthews.com/logos2/virginia.jpg MONTREAL, QUEBEC and QUEBEC CITY, QUEBEC --
Sign-up for ISS Recommends That Osisko and Virginia Shareholders Vote FOR the Business Combination investment picks
2015/1/27
MILPITAS, Calif.
Sign-up for ISSI Announces First Fiscal Quarter 2015 Results investment picks
2015/1/20
MILPITAS, Calif.
Sign-up for ISSI Announces Fiscal 2015 First Quarter Conference Call investment picks
2015/1/12
MILPITAS, Calif.
Sign-up for ISSI Announces Preliminary December Quarter Revenue Results investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: iShares Leads Global ETF Industry Flows with $102.8bn in 2014 to ISSI Announces Preliminary December Quarter Revenue Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent